Mesenchymal stem cells: A promising targeted-delivery vehicle in cancer gene therapy
- 15 October 2010
- journal article
- review article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 147 (2), 154-162
- https://doi.org/10.1016/j.jconrel.2010.05.015
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2009
- Targeted delivery of doxorubicin using stealth liposomes modified with transferrinInternational Journal of Pharmaceutics, 2009
- Drug targeting and tumor heterogeneityJournal of Controlled Release, 2009
- Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis modelGene Therapy, 2008
- Adipose Tissue–Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene TherapyCancer Research, 2007
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Inflammation and cancerNature, 2002
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001
- The Hallmarks of CancerCell, 2000